249 related articles for article (PubMed ID: 37175931)
1. Oxidative Stress, Inflammatory, Angiogenic, and Apoptotic molecules in Proliferative Diabetic Retinopathy and Diabetic Macular Edema Patients.
Andrés-Blasco I; Gallego-Martínez A; Machado X; Cruz-Espinosa J; Di Lauro S; Casaroli-Marano R; Alegre-Ituarte V; Arévalo JF; Pinazo-Durán MD
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175931
[TBL] [Abstract][Full Text] [Related]
2. Vitreous inflammatory and angiogenic factors on patients with proliferative diabetic retinopathy or diabetic macular edema: the role of Lipocalin2.
Batsos G; Christodoulou E; Christou EE; Galanis P; Katsanos A; Limberis L; Stefaniotou M
BMC Ophthalmol; 2022 Dec; 22(1):496. PubMed ID: 36536319
[TBL] [Abstract][Full Text] [Related]
3. Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients.
Brzović-Šarić V; Landeka I; Šarić B; Barberić M; Andrijašević L; Cerovski B; Oršolić N; Đikić D
Mol Vis; 2015; 21():649-64. PubMed ID: 26120270
[TBL] [Abstract][Full Text] [Related]
4. Concurrent alteration in inflammatory biomarker gene expression and oxidative stress: how aerobic training and vitamin D improve T2DM.
Hoseini R; Rahim HA; Ahmed JK
BMC Complement Med Ther; 2022 Jun; 22(1):165. PubMed ID: 35733163
[TBL] [Abstract][Full Text] [Related]
5. Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.
Abu El-Asrar AM; Ahmad A; Alam K; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
Acta Ophthalmol; 2018 Jun; 96(4):e460-e467. PubMed ID: 29098793
[TBL] [Abstract][Full Text] [Related]
6. Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body.
Izuta H; Matsunaga N; Shimazawa M; Sugiyama T; Ikeda T; Hara H
Mol Vis; 2010 Jan; 16():130-6. PubMed ID: 20142849
[TBL] [Abstract][Full Text] [Related]
7. Lipid peroxidation in proliferative vitreoretinopathies.
Verdejo C; Marco P; Renau-Piqueras J; Pinazo-Duran MD
Eye (Lond); 1999 Apr; 13 ( Pt 2)():183-8. PubMed ID: 10450379
[TBL] [Abstract][Full Text] [Related]
8. Role of Oxidative Stress and Severity of Diabetic Retinopathy in Type 1 and Type 2 Diabetes.
Bokhary K; Aljaser F; Abudawood M; Tabassum H; Bakhsh A; Alhammad S; Aleyadhi R; Almajed F; Alsubki R
Ophthalmic Res; 2021; 64(4):613-621. PubMed ID: 33498043
[TBL] [Abstract][Full Text] [Related]
9. Two cases of diabetic macular edema complicated by an atypical macular hole.
Yoshida Y; Sato T; Oosuka S; Mimura M; Fukumoto M; Kobayashi T; Kida T; Ikeda T
BMC Ophthalmol; 2020 Apr; 20(1):171. PubMed ID: 32349686
[TBL] [Abstract][Full Text] [Related]
10. High vitreous concentration of IL-6 and IL-8, but not of adhesion molecules in relation to plasma concentrations in proliferative diabetic retinopathy.
Koskela UE; Kuusisto SM; Nissinen AE; Savolainen MJ; Liinamaa MJ
Ophthalmic Res; 2013; 49(2):108-14. PubMed ID: 23257933
[TBL] [Abstract][Full Text] [Related]
11. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
[TBL] [Abstract][Full Text] [Related]
12. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
[TBL] [Abstract][Full Text] [Related]
13. (Pro)renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy.
Kanda A; Noda K; Saito W; Ishida S
Diabetologia; 2012 Nov; 55(11):3104-13. PubMed ID: 22930161
[TBL] [Abstract][Full Text] [Related]
14. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
15. Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes.
Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Melia M; Chen E; Pavlica MR; Jampol LM;
Ophthalmology; 2018 Nov; 125(11):1776-1783. PubMed ID: 29980333
[TBL] [Abstract][Full Text] [Related]
16. Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment.
Tuuminen R; Sahanne S; Loukovaara S
Acta Ophthalmol; 2014 Nov; 92(7):675-81. PubMed ID: 24506800
[TBL] [Abstract][Full Text] [Related]
17. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy.
Kawashima M; Shoji J; Nakajima M; Kamura Y; Sato Y
Jpn J Ophthalmol; 2007; 51(2):100-4. PubMed ID: 17401618
[TBL] [Abstract][Full Text] [Related]
18. Increased intravitreous interleukin-18 correlated to vascular endothelial growth factor in patients with active proliferative diabetic retinopathy.
Song Z; Sun M; Zhou F; Huang F; Qu J; Chen D
Graefes Arch Clin Exp Ophthalmol; 2014 Aug; 252(8):1229-34. PubMed ID: 24531563
[TBL] [Abstract][Full Text] [Related]
19. Elevated protein carbonyl and HIF-1α levels in eyes with proliferative diabetic retinopathy.
Loukovaara S; Koivunen P; Inglés M; Escobar J; Vento M; Andersson S
Acta Ophthalmol; 2014 Jun; 92(4):323-7. PubMed ID: 23718695
[TBL] [Abstract][Full Text] [Related]
20. Elevation of angiogenic factor Cysteine-rich 61 levels in vitreous of patients with proliferative diabetic retinopathy.
You JJ; Yang CM; Chen MS; Yang CH
Retina; 2012 Jan; 32(1):103-11. PubMed ID: 21822163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
